avapro has been researched along with Apnea, Sleep in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Excerpt | Relevance | Reference |
---|---|---|
"ARB prevents chronic sleep apnea-enhanced cardiac apoptosis via enhancing survival pathways." | 1.72 | Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation. ( Huang, CY; Lee, SD; Lin, CY; Lin, YY; Liou, YF; Pai, PY; Wong, JKS; Wu, XB; Yu, SH, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Pai, PY | 1 |
Lin, YY | 1 |
Yu, SH | 1 |
Lin, CY | 1 |
Liou, YF | 1 |
Wu, XB | 1 |
Wong, JKS | 1 |
Huang, CY | 1 |
Lee, SD | 1 |
1 other study available for avapro and Apnea, Sleep
Article | Year |
---|---|
Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Hypo | 2022 |